MedPath

Clinical Performance of Existing Wearers of Avaira Sphere Following a Refit With Clariti Elite Sphere

Not Applicable
Completed
Conditions
Myopia
Interventions
Device: somofilcon A
Registration Number
NCT02248727
Lead Sponsor
Coopervision, Inc.
Brief Summary

The aim of this dispensing study is to evaluate the clinical performance of existing wearers of Avaira sphere lenses following a refit with Clariti Elite sphere over 4 weeks of daily wear.

Detailed Description

This is a 30-subject, prospective dispensing study comparing the clinical performance of the subjects' habitual Avaira sphere lenses following a refit with Clariti Elite sphere lenses. Subject's habitual Avaira sphere lenses will be evaluated at the first visit and then re-fitted with a pair of Clariti Elite sphere lenses for 4 weeks of daily wear. After the dispensing visit, subjects will return for evaluations at 1 week, 2 weeks and 4 weeks.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
30
Inclusion Criteria
  • Is between 18 and 40 years of age (inclusive)
  • Has had a self-reported visual exam in the last two years
  • Is an adapted Avaira sphere contact lens (CL) wearer (at least 1 week in Avaira sphere)
  • Has a contact lens spherical prescription between -1.00 to - 6.00 (inclusive)
  • Has a spectacle cylinder up to 0.75D in each eye.
  • Can achieve best corrected spectacle distance visual acuity of 20/25 (0.10 logMAR) or better in each eye.
  • Can achieve a distance visual acuity of 20/30 (0.18 logMAR) or better in each eye with the study contact lenses.
  • Has clear corneas and no active ocular disease
  • Has read, understood and signed the information consent letter.
  • Patient contact lens refraction should fit within the available parameters of the study lenses.
  • Is willing to comply with the wear schedule (at least 5 days per week, > 8 hours/day assuming there are no contraindications for doing so).
  • Is willing to comply with the visit schedule
Exclusion Criteria
  • Is not a habitual wearer of Avaira sphere lenses

  • Has a contact lens prescription outside the range of the available parameters of the study lenses.

  • Has a spectacle cylinder ≥1.00D of cylinder in either eye.

  • Has a history of not achieving comfortable CL wear (5 days per week; > 8 hours/day)

  • Has contact lens best corrected distance vision worse than 20/25 (0.10 logMAR) in either eye.

  • Presence of clinically significant (grade 2-4) anterior segment abnormalities

  • Presence of ocular or systemic disease or need of medications which might interfere with contact lens wear.

  • Slit lamp findings that would contraindicate contact lens wear such as:

    • Pathological dry eye or associated findings
    • Pterygium, pinguecula, or corneal scars within the visual axis
    • Neovascularization > 0.75 mm in from of the limbus
    • Giant papillary conjunctivitis (GCP) worse than grade 1
    • Anterior uveitis or iritis (past or present)
    • Seborrheic eczema, Seborrheic conjunctivitis
    • History of corneal ulcers or fungal infections
    • Poor personal hygiene
  • Has a known history of corneal hypoesthesia (reduced corneal sensitivity)

  • Has aphakia, keratoconus or a highly irregular cornea.

  • Has Presbyopia or has dependence on spectacles for near work over the contact lenses.

  • Has undergone corneal refractive surgery.

  • Is participating in any other type of eye related clinical or research study.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
enfilcon Asomofilcon AAll participants are habitual wearers of enfilcon A lens and who are refitted with somofilcon A lens
somofilcon Asomofilcon AAll participants are habitual wearers of enfilcon A lens and who are refitted with somofilcon A lens
Primary Outcome Measures
NameTimeMethod
Visual Acuity - Enfilcon A and Somofilcon ABaseline, 1 Week, 2 Week, 4 Week

Monocular and binocular logMAR visual acuity for enfilcon A / somofilcon A assessed at baseline and somofilcon A lenses assessed at 1 week, 2 week, 4 week.

Subjective Assessments. - Enfilcon A and Somofilcon ABaseline, 1 Week, 2 Week, 4 Week

Subjective assessments for: comfort, dryness, handling, overall vision satisfaction, and eye whiteness. Enfilcon A was assessed at baseline and somofilcon A lenses assessed at 1 week, 2 week, 4 week. Scale(s): comfort (0=very poor; 10=excellent), dryness (0=very dry; 10=no dryness), handling (0=very difficult; 10=very easy), overall vision satisfaction (0=very unsatisfied; 10=very satisfied), habitual eye whiteness (0=not white; 10= totally white)

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Optometry Research Group (GIO) Optics Department, University of Valencia

🇪🇸

Valencia, Spain

© Copyright 2025. All Rights Reserved by MedPath